THE POLIOMYELITIS IMMUNIZATION PROGRAMME

Size: px
Start display at page:

Download "THE POLIOMYELITIS IMMUNIZATION PROGRAMME"

Transcription

1 Vol. 6, No. 2. June, THE POLIOMYELITIS IMMUNIZATION PROGRAMME IN SINGAPORE By L. H. Lee, M.B.,B.S., K. A. Lim, B.Sc., M.B., Ch.B., Dip. Bact. and K. Kanagaratnam, M.B., B.S., D.P.H., (From the Department of Bacteriology, University of Singapore, Singapore 3, Malaysia). Infection by poliovirus is usually inapparent. Occasionally, there may be a minor illness with symptoms of fever, headache and gastrointestinal disturbance. This is the extent of the clinical picture in the majority of cases. However, in a small percentage of cases there is involvement of the central nervous system which is expressed clinically as either "aseptic meningitis" or"paralytic poliomyelitis". It is this latter syndrome with flaccid paralysis as a prominent feature followed by residual permanent disability that makes poliomyelitis a disease of public health importance. For many years in the State of Singapore the incidence of paralytic poliomyelitis has been noted carefully (Lee, Lim and Tye, 1964). The disease is notifiable, and because of its rather alarming and distinctive features medical care is inevitably sought so that every case comes to the attention of the health authorities. The cases that might be missed are possibly those which are fulminating and succumb before a diagnosis is made; their number, however, must be insignificant. Since 1959, all notified cases of paralytic poliomyelitis have been investigated and laboratory confirmation attempted in each instance. In this way, a clear picture of poliomyelitis in Singapore has been obtained. The epidemio- b 10 to E...t1I fi u.t I%S I% NS 1EE1 1%1 Mt Lt IIÌIIIIII I II,I.tlli.t.lE.. MONTHLY INCIDENCE OF POLIOMYELITIS Fig. 1. Monthly incidence, by date of onset, of paralytic poliomyelitis in Singapore for the years logical pattern of poliomyelitis in Singapore is that of an endemic disease breaking out periodically in epidemic form. Children below 5 years of age were those most at risk, particularly those in the very young age-group of six months to two years. Poliovirus type I was responsible for the majority of cases and for the epidemic waves. Poliovirus type 3 was of minor importance and type 2 comparatively unimportant. (Lee, Lim and Tye, 1964). Figure 1 shows the monthly incidence of paralytic poliomyelitis, by date of onset, for the past six years, and Table I shows the serological types of the polio - viruses isolated from notified cases. TABLE I VIRUSES ISOLATED FROM NOTIFIED CASES OF POLIOMYELITIS RESULT TOTAL Poliovirus Type Poliovirus Type 2 2 I Poliovirus Type I 38 Other cytopathogenic agents Negative No specimen Total notified cases Deputy Director of Medical Services (Health), Ministry of Health, Singapore.

2 90 SINGAPORE MEDICAL JOURNAL In 1958, there occurred an epidemic of poliomyelitis due to type 1 virus which extended into the early months of 1959, and involved over 400 cases. Oral poliovaccine was used for the first time on a mass scale in Singapore in an attempt to modify the course of the epidemic. The results were reported by Hale et al. (1959). Poliovaccine type 2 was fed to about 200,000 children to provide protection by interfering with the establishment of the epidemic virus type. An analysis of the data from this campaign showed that there was a substantial reduction in the risk of paralytic disease as a result of the vaccination (Knowelden, Hale, Gardner and Lee, 1961). In 1960 a Committee appointed by the Singapore Government carried out a serological and faecal survey to assess the immune status of children and to siudy the results of the type 2 vaccination campaign. The findings were submitted in a Report to the Ministry of Health, Singapore (1961). The Committee recognised that poliomyelitis would increase unless active preventative measures were adopted and recommended a. programme of immunization with oral poliovaccine for the control of poliomyelitis in the State. This programme was approved and executed by the Government's Public Health Division. Monovalent oral poliovaccine was imported as vaccine concentrate and after dilution, made up into polyvalent packs containing either types 1 and 3 cr types 1, 2 and 3 by the Department of Bacteriology of the University of Singapore. Magnesium chloride was incorporated in the diluted vaccine in molar concentration as stabiliser (Wallis and Melnick, 1961). Stocks of diluted vaccine were prepared for current requirements and stored frozen at -200C. until issued to various clinics and immunization teams. The storage of the vaccine in the clinic refrigerators was at the temperature of 00 to 40C. Although unfrozen vaccine stored in this way is stated to maintain its potency for at least six months, departmental instructions ensure that no vaccine in use was stored for more than three months, and as far as possible only a supply of vaccine for the period of six weeks was carried by a clinic. Mobile teams conveyed the vaccine in thermos flasks which were stored overnight in a central_ refrigerator. The first phase of the poliomyelitis immunization programme began in March At Maternal and Child Health Centres, totalling 34 in the city and rural areas, one or two sessions per week were set aside for different types of immunization, and parents bringing their children for immunization against diphtheria, pertussis and tetanus were urged to accept poliovaccine as well. In practice, the procedure was very popular and there was little "sales resistance" to a vaccine that was given orally. The children served by the Maternal and Child Health Centres were mostly six years of age and below. By November 1962, 205,000 children constituting a coverage of approximately 60% of the age -group concerned had received two doses of trivalent, i.e., types I, 2 and. 3, vaccine. The British Medical Research Council trials (P.H.L.S., 1961) had shown that three doses of trivalent vaccine gave good results, but it was decided to give initially only two doses of trivalent vaccine, three months apart. The immune response to this regime was studied in a group of children who had no antibody to all three poliovirus types prior to immunization. It was found that the conversion rate was only 50 % for type 1 poliovirus, 98.5% for type 2 and 58.8% for type 3. Thus two doses of trivalent vaccine were inadequate since protection against type 1 and type 3 poliomyelitis was considered much more important epidemiologically than protection against type 2. Nevertheless, it was gratifying to note that the incidence of poliomyelitis in that year dropped to a new low figure of 14 and during the months of July to November not a single case of paralytic poliomyelitis was notified. It seemed reasonable to assume that this was to some extent the consequence of the vaccination campaign. To complete the immunization, the children were advised to return for a further dose. The numbers that responded were 29,331 in 1963 and 17,891 in 1964 giving a total of 47,222 (23 %) children who could be said to have completed their course of immunization begun in The experience gained indicated a need to revise the vaccination schedule which was now altered to two doses of bivalent vaccine containing types 1 and 3 followed by one dose of trivalent vaccine. Since type I and type 3 polio - viruses were responsible for the majority of -cases it was considered desirable to immunize

3 June, with these types initially and to include these types even when immunizing with type 2 vaccine. Type 2 vaccine was omitted from the first two doses to increase the efficiency of immunization against types 1 and 3 since type 2 virus in a trivalent mixture tends to interfere with the immune response to the other types. It should also be noted that the rate of natural occurring enteroviruses is high in Singapore. About 20% of children at any time are excreting some type of enterovirus which could interfere with the establishment of vaccine virus and cause a failure of immune response. For this reason, repeated administration of vaccine is advocated. The second phase of the immunization programme with the amended schedule was introduced in March This was the primary immunization of children in the first year of life. Infants in Singapore attend the Maternal and Child Health Centres for vaccination against diphtheria which is compulsory. In practice they are immunized against diphtheria, pertussis and tetanus simultaneously. Advantage is taken of their attendance to offer them oral poliovaccine which is accepted by the majority. The interval between doses is one month. The programme has now become routine, and Table II gives the number of children up to six years of age that were immunized with poliovaccine in 1963 and Approximately 30,000 children in 1963 and 50,000 in 1964 may be regarded as having completed their primary course. This rate of immunization would be considered satisfactory, in view of the birth rate of 60,000 per annum in Singapore, if it is continued in future years. The totals for children who receive one or two doses include some of those who received three doses subsequently in that year, but also include those who for some reason or other failed to complete the course. The protection given to these children although not considered complete contributes significantly to the overall immunity of the population. Under ideal conditions, the three -dose programme may be expected to confer protection against all three poliovirus types on every child so immunized. However, interference from naturally occurring enteroviruses, and other non-specific factors may in some instances prevent the acquisition of immunity. In consideration of this, a fourth dose was recommended as a "booster", generally to be given to children in the year following primary immunization. Introduced in 1964, the booster doses have attracted only relatively small numbers, and the returns are also shown in Table II. Nearly 60,000 children about 7 years of age entered school for the first time in TABLE II ORAL POLIOVACCINE INOCULATIONS IN HEALTH CENTRES AND SCHOOLS POLIOVACCINE HEALTH CENTRES HEALTH CENTRES SCHOOLS 1st dose Types 1 & 3 54,594 51,841 33,640 2nd dose Types 1 & 3 39,339 50,518 29,471` 3rd dose Types I, 2 & 3 31,008 49,893 4th dose Types 1, 2 & 3-8,455-3rd dose for 1962 campaign Types 1, 2 & 3 29,331 17,891 - Total 154, ,598 63,111 The 2nd dose in schools was of trivalent vaccine.

4 92 SINGAPORE MEDICAL JOURNAL Many of these had been immunized in the 1962 campaign when they received two doses of trivalent vaccine. The Schools' Health teams who visited the schools to carry out diphtheria immunizations also inoculated with parental consent those children who had missed the 1962 campaign, with one dose of bivalent and one dose of trivalent vaccine. Nearly 30,000 school children were so immunized as shown in Table II which also gives the totals for children receiving the 3rd dose of the course commenced in The implementation of the poliomyelitis immunization programme in all its aspects as described was accompanied by a marked decrease in the incidence of paralytic poliomyelitis during the past three years as seen in Figure I, compared with the incidence in earlier years. Table III gives the poliomyelitis incidence with the standardised case and death rates for the past ten years. The primary data used for this table are the number of cases occurring according to the date of notification. Elsewhere in this paper cases are recorded according to date of onset since this may be of relevance when vaccination dates are also considered. The difference in approach accounts for some discrepancy in case incidence in some years because a case occurring at the end of the year may be notified in the following year. [n 1963,74 cases of paralytic poliomyelitis were notified. Of these, 64 occurred as a minor epidemic in the latter half of that year, a grave disappointment in view of the encouraging returns of the preceding twelve months. Fiftyseven (77%) of the cases were children between six months and two years of age. Type 1 polio - virus was isolated from 39 cases, type 2 from three cases and type 3 from one case. It is reasonable to believe that the epidemic occurred TABLE 1[I OF POLIOMYELITIS SINCE 1955 WITH STANDARDISED CASE AND DEATH RATES INCIDENCE' YEAR Cases Deaths Case Fatality 12.5% 2.2% 10.4% 3.2% 6.3% Population 1,305,500 1,371,600 1,445,929 1,514,000 1,579,600 Cases/ 100, Deaths/ 100, YEAR Cases Deaths Case Fatality 3.1% 8.8% 7.1% 2.9% 10.5% Population 1,634,100 1,687,300 1,732, ,200 1,820,000 Cases/ 100, Deaths/100, * According to date of notification.

5 93 JUNE, in a population of susceptibles that had been built up in the interval between the 1962 campaign following which there were five months without case notifications and the beginning of the 1963 immunization programme. It is pertinent to indicate that the notified cases include 11 (14.7%) who had received oral poliovaccine. Seven of them had received one dose and 4 had received two doses. The particulars of these cases together with the intervals between vaccination and onset of disease are given in Table IV. One other case who received one dose of vaccine on the day of onset has been omitted from our data. The outstanding fact was that no child who had received three doses of vaccine, the recommended primary course of immunization, contracted paralytic poliomyelitis, a very practical demonstration of the effectiveness of the immunization programme. This conclusion was further borne out in 1964 when out of 11 cases spread out through the year, only one child had received oral polio - vaccine. Indeed, this child received two doses of trivalent vaccine in 1962 and did not take the third dose. A question which arises from the data presented in Table IV is whether any of the cases occurring in the vaccinees were attributable to vaccine virus that was "insufficiently" attenuated. Such a doubt is difficult to dispel in the individual case, and it is true that four of the cases who received only one dose of vaccine contracted paralytic poliomyelitis within the possible incubation period. However, until poliomyelitis has been eradicated from Singapore and the introduction of infection from elsewhere prevented, there must be occasionally cases in susceptible children who chanced to receive vaccine about the time of infection. The probability of such a coincidence occurring is very high in view of the large numbers of children being immunised. Fear that cases may be attributable to vaccine virus cannot be supported from the data presented. There is further the point that even if some of the cases were, indeed, caused by vaccine virus, they were very TABLE IV PARALYTIC POLIOMYELITIS CASES IN VACCINEES, 1963 Name Sex Age (Years) Date of vaccination Onset of Symptoms Vaccination/ Onset interval Faeces Isolation A.G. F 4-4/ days Polio 3 T.K.H. M 7( days Polio 1 I-I.A. M I - 10/ days Negative A.G.H. F 1-5/ months Coxs. A9 C.J. F days No specimen L.B.W. F 1-9/ days Polio 1 L.S.K. M 1-10/ months Polio 1 B.C.M. F months Negative N.S.K. F 1-4/ months Polio 1 C.S. M 1 Feb. 63 Mar months Negative L.M.H. F I - 3/ months Negative

6 94 SINGAPORE MEDICAL JOURNAL few compared to the number of cases that could have been expected to occur in the absence of general immunization with oral poliovaccine. DISCUSSION It is well known that many communicable diseases show declining rates as community standards of living are raised, quite apart from the influence of specific measures such as immunization. In regard to poliomyelitis, improvements in social economic conditions lead to reduction of immunization through natural infection and increasing hazard of large scale epidemic outbreaks. Thus, in Singapore, the epidemiological evidence indicates that conditions were being created when large scale outbreaks such as that which occurred in 1958 would inevitably recur in the absence of specific measures. The introduction of a vaccination programme has replaced immunization through natural infection with its risk of paralysis by artificial immunization with attenuated virus. Epidemics of poliomyelitis have been rendered unlikely and the annual incidence of disease is reduced to negligible numbers. An important consequence of the fall in poliomyelitis incidence is on the work of the Infectious Diseases Hospital which takes care of patients and of the Orthopaedic Units of the General Hospital which undertake the rehabilitation of cases with residual disability. Somewhat less than half the patients have minor or no sequelae and are discharged as "cured" after one or two months hospitalization. The larger proportion of cases may stay in hospital for as long as six months or even for years. The management of a poliomyelitis case often extends from early childhood to adolescence. The effect of such a long separation of very young children from the home environment is extremely unhappy, and should be seen with comparative rarity in future. The Orthopaedic Units, hitherto, have had their attention almost entirely engaged by the treatment of recent cases that were in the immediate post -convalescent stage. With the reduction in the number of fresh cases, the Orthopaedic Units have now been able to turn their attention to old cases for more leisurely planned corrective and plastic surgical treatment. It is clear that the cost and effort involved in the implementation of the poliomyelitis immunization programme has been justified by the results. It is extremely difficult, however, to assess accurately what proportions of children in different age -groups have been immunised in the establishment of the population immunity to poliomyelitis. One way of estimating the degree of immunization performed is to consider the total amount of oral vaccine fed into the population. In 1963, vaccine was fed on more than 150,000 occasions, either of bivalent or trivalent vaccine which included type t and type 3 vaccine. Thus type 1 poliovaccine and type 3 poliovaccine were both given 150,000 times in The number of children who received vaccine is much less than this figure since most children take the vaccine more than once. There were 410,300 children in the age -groups up to six years on This is the population age -group to which the immunization programme was directed. The corresponding figures for 1964, omitting those vaccinated in schools were 180,000 feeds of vaccine to a population age -group of 413,700 children up to six years on Thus, the average annual rate of immunization, in the two years under consideration was 40,000 vaccine feeds per 100,000 children per year. The fact that many of these children received trivalent vaccine in 1962 and some even, type 2 vaccine in 1958 should also be taken into account. Another approach in assessing what has been achieved in immunization is to consider the proportion of children who have received the full primary course of three doses. In 1964, 24,000 children below one year of age completed three doses. There were about 60,000 children of this age, so approximately 40% of children below one year of age completed the primary course of immunization against poliomyelitis. Some children for various reasons were not immunized in the first year of life as recommended but completed the schedule subsequently. Separate returns for the immunization of one -year -old children were not available for 1964 but returns for the first three months of 1965 showed that the number of one -year-old children who completed the primary course were 978, 807, and 1,095, respectively. There were 58,000 children of this age so the average monthly immunization rate was 1.7% and the annual immunization rate was 20%. If this 20% rate for one -year-old children is added to the 40% for children who were below one year in the previous year, an immunization rate of 60%

7 JUNE is obtained for this birth cohort before their second birthday. As the immunization programme is continued into future years, the aim should be to complete primary immunization of children against poliomyelitis in the first year of life since the incidence of paralytic poliomyelitis is greatest in the age -group up to two years. The rates of immunization that have been achieved should be maintained if not surpassed. There is always the danger that public response may slacken as the "danger" of poliomyelitis appears to recede. Sustained effort in public health education and continued diligence of the staff of Health Centres in persuading parents to have their children immunized is the only way by which our population immunity so arduously acquired would be retained. SUMMARY After a careful study of prevailing epidemiological conditions regarding poliomyelitis in Singapore, a programme of immunization with oral poliovaccine was instituted for the control of the disease. The programme began with a mass campaign in 1962 when children up to six years of age were inoculated with two doses of trivalent oral poliovaccine three months apart. Subsequently the children were advised to return for a third dose and 23% of children in the age -groups concerned completed the schedule of three doses. In 1963, the programme was extended by the inauguration of primary immunization of children in the first year of life with two doses of bivalent (types 1 and 3) oral poliovaccine and one dose of trivalent vaccine in that order one month apart. At the same time, children attending school for the first time who had not previously received vaccine were also given one dose of bivalent and one dose of trivalent vaccine. The programme was continued into 1964, Notifications of paralytic poliomyelitis has in consequence dropped dramatically. In 1962 there were 14 cases; in 1963, 74 cases; and in 1964, 11 cases. No child who had completed the primary immunization schedule of three doses contracted paralytic poliomyelitis. Seven cases in 1963 had received one dose and four had received two doses of -vaccine. In 1964, one of the cases had received two doses of vaccine. It is calculated that in 1963, 150,000 administrations of vaccine either bivalent or trivalent were given to children up to six years of age. In 1964, the number was 180,000. The population of these age -groups in those years were, respectively 410,300 and 413,700, giving an average annual vaccination rate of 40,000 vaccine feeds per 100,000 children. The rate at which young children in the first two years of life were being given the complete primary course of three doses of vaccine is calculated at 60%. It is considered that the incidence of paralytic poliomyelitis can be kept at very low levels if the programme described is maintained. ACKNOWLEDGEMENTS We are grateful to the Director of Medical Services, Singapore, for permission to quote from departmental records. It is a pleasure to acknowledge the helpful collaboration of the staff of the Singapore Government Medical Department, especially Dr. K. W. Leong, Medical Superintendent, Middleton Hospital, Dr. Maggie Lim, Senior Health Officer in Charge, Maternal and Child Health Service, Dr. Tan Kah Hong, Senior Health Officer in Charge, School Health Service, and the doctors and nurses concerned with the poliomyelitis immunization programme. Our thanks are also due to Mr. K. Panjanathan for technical assistance of high competence. REFERENCES Hale, J.H., Lee, L.H., Doraisingham, M., Kanagaratnam, K., Leong, K.W., and Monteiro, E.S. (1959) Large-scale use of Sabin Type 2 Attenuated Poliovirus Vaccine in Singapore during a Type I Poliomyelitis Epidemic. Brit. med. J. 1, Knowelden, J., Hale, J.H., Gardner, P.S., Lee, L.H. (1961) Measurement of the Protective Effect of Attenuated Poliovirus Vaccine. Brit. med. J., I, Lee. L.H., Lim, K.A., Tye, C.Y. (1964) Prevention of Poliomyelitis in Singapore by Live Vaccine. Brit. med. J., I, Ministry of Health, Singapore (1961) Report of Committee on Poliomyelitis. Public Health Laboratory Service (1961) Trial of Living Attenuated Poliovirus Vaccine. Brit. med., J., 2, Wallis, C., Melnick, J.L. (1961) Stabilization of Polio - virus by Cations. Tex. Rep. Biol. Med.,

Polio vaccines and polio immunization in the pre-eradication era: WHO position paper. Published in WER 4 June, 2010

Polio vaccines and polio immunization in the pre-eradication era: WHO position paper. Published in WER 4 June, 2010 Polio vaccines and polio immunization in the pre-eradication era: WHO position paper Published in WER 4 June, 2010 Epidemiology & Background Poliomyelitis (polio) is an acute communicable disease of humans

More information

VII THE CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE 7. 7

VII THE CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE 7. 7 VII THE CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE IMMUNISATION PROGRAMME IN 2002 7. 7 The childhood immunisation programme in Singapore offers vaccination against tuberculosis, hepatitis B, diphtheria,

More information

Determination Of Thermal Stability Of Oral Polio Vaccine (Opv) At Different Temperature Under Laboratory Conditions

Determination Of Thermal Stability Of Oral Polio Vaccine (Opv) At Different Temperature Under Laboratory Conditions Determination Of Thermal Stability Of Oral Polio Vaccine (Opv) At Different Temperature Under Laboratory Conditions Muhammad T 1, SS Baba 2, LT Zaria 2, AD El-Yuguda 2 And IB Thilza 3, 1 who National Polio

More information

NHS public health functions agreement

NHS public health functions agreement NHS public health functions agreement 2016-17 Service specification No.4 Immunisation against diphtheria, tetanus, poliomyelitis, pertussis and Hib programme Classification: official NHS England INFORMATION

More information

Classification: official 1

Classification: official 1 NHS public health functions agreement 2018-19 Service specification No.4 Immunisation against diphtheria, tetanus, poliomyelitis, pertussis, Hib and HepB programme 1 NHS public health functions agreement

More information

Polio (Paralytic and Non-paralytic

Polio (Paralytic and Non-paralytic Polio (Paralytic and Non-paralytic Infection) rev Jan 2018 Infectious Agent Poliovirus (genus Enterovirus) types, 1, 2, and 3. BASIC EPIDEMIOLOGY Transmission Poliovirus is transmitted by person-to-person

More information

NHS public health functions agreement Service specification No.9 DTaP/IPV and dtap/ipv pre-school booster immunisation programme

NHS public health functions agreement Service specification No.9 DTaP/IPV and dtap/ipv pre-school booster immunisation programme NHS public health functions agreement 2018-19 Service specification No.9 DTaP/IPV and dtap/ipv pre-school booster immunisation programme 1 NHS public health functions agreement 2018-19 Service specification

More information

OVERVIEW OF THE NATIONAL CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE

OVERVIEW OF THE NATIONAL CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE OVERVIEW OF THE NATIONAL CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE Dr Tiong Wei Wei, MD, MPH Senior Assistant Director Policy and Control Branch, Communicable Diseases Division Ministry of Health 9

More information

NHS public health functions agreement Service specification No.12 Td/IPV (teenage booster) immunisation programme

NHS public health functions agreement Service specification No.12 Td/IPV (teenage booster) immunisation programme NHS public health functions agreement 2018-19 Service specification No.12 Td/IPV (teenage booster) immunisation programme NHS public health functions agreement 2018-19 Service specification No.12 Td/IPV

More information

Potency Titration of Oral Polio Vaccine by Estimation of Live Virus Content Using Tissue Culture Technique

Potency Titration of Oral Polio Vaccine by Estimation of Live Virus Content Using Tissue Culture Technique Journal of Applied Sciences Research, 6(3): 229-233, 20 20, INSInet Publication Potency Titration of Oral Polio Vaccine by Estimation of Live Virus Content Using Tissue Culture Technique 1 2 2 3 4 6 2

More information

ACCEPTANCE OF MEASLES VACCINE IN SIX MATERNAL AND CHILD HEALTH CENTRES

ACCEPTANCE OF MEASLES VACCINE IN SIX MATERNAL AND CHILD HEALTH CENTRES ACCEPTANCE OF MEASLES VACCINE IN SIX MATERNAL AND CHILD HEALTH CENTRES D.I. PAKSHONG S.L. LOW S.L. LAM SYNOPSIS Measles vaccine was offered on a trial basis to 2,184 parents of infants and preschool children

More information

Pertussis immunisation for pregnant women

Pertussis immunisation for pregnant women Pertussis immunisation for pregnant women Introduction The routine childhood immunisation programme has been very effective in reducing the overall numbers of cases of pertussis. Before the introduction

More information

D.A.Henderson, MD, MPH. Professor of Medicine, University of Pittsburgh Honorary Fellow, London School of Hygiene and Tropical Medicine

D.A.Henderson, MD, MPH. Professor of Medicine, University of Pittsburgh Honorary Fellow, London School of Hygiene and Tropical Medicine Polio Eradication a reconsideration of strategy D.A.Henderson, MD, MPH Professor of Medicine, University of Pittsburgh Honorary Fellow, London School of Hygiene and Tropical Medicine Baltimore, Maryland

More information

National Action Plan for Response to Poliovirus Importation

National Action Plan for Response to Poliovirus Importation Public Health Res Perspect 2011 2(1), 65e71 doi:10.1016/j.phrp.2011.04.003 pissn 2210-9099 eissn 2233-6052 - BRIEF REPORT - National Action Plan for Response to Poliovirus Importation Kyung Min Song a,

More information

Staff Immunisation Policy

Staff Immunisation Policy Policy No: IC05 Version: 8.0 Name of Policy: Staff Immunisation Policy Effective From: 18/08/2015 Date Ratified 15/07/2015 Ratified Infection Prevention & Control Committee Review Date 01/07/2017 Sponsor

More information

Preparing for the withdrawal of all oral polio vaccines (OPVs): Replacing trivalent OPV with bivalent OPV

Preparing for the withdrawal of all oral polio vaccines (OPVs): Replacing trivalent OPV with bivalent OPV Preparing for the withdrawal of all oral polio vaccines (OPVs): Replacing trivalent OPV with bivalent OPV Frequently Asked Questions February 2015 Table of Contents Rationale for OPV cessation... 2 About

More information

Family and Travel Vaccinations

Family and Travel Vaccinations Family and Travel Vaccinations We offer the full range of baby, child and family vaccinations. We are able to tailor schedules to your child s needs or international schedule. We have a suggested vaccination

More information

History and aims of immunisation. Dr Anna Clarke Department of Public Health Dr. Steevens Hospital Dublin 8

History and aims of immunisation. Dr Anna Clarke Department of Public Health Dr. Steevens Hospital Dublin 8 History and aims of immunisation Dr Anna Clarke Department of Public Health Dr. Steevens Hospital Dublin 8 Objectives To examine the history of immunisation To explain the aim of immunisation To develop

More information

The Danish childhood vaccination program SUMMARY IN ENGLISH

The Danish childhood vaccination program SUMMARY IN ENGLISH The Danish childhood vaccination program SUMMARY IN ENGLISH 2018 Why do we vaccinate children in Denmark? Childhood immunization programs are some of the most effective preventive public health measures

More information

KURUKSHETRA JULY 2017 RURAL HEALTH

KURUKSHETRA JULY 2017 RURAL HEALTH KURUKSHETRA JULY 2017 RURAL HEALTH Jagat Prakash Nadda is the Union Minister of Health and Family Welfare. Immunization, or immunisation, is the process by which an individual's immune system becomes

More information

Expanded Programme on Immunization (EPI)

Expanded Programme on Immunization (EPI) Timor-Leste 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles

More information

Rotavirus. Factsheet for parents. Immunisation for babies up to a year old

Rotavirus. Factsheet for parents. Immunisation for babies up to a year old Rotavirus Factsheet for parents This factsheet describes the rotavirus infection and the vaccine that protects against it. It also provides the background to the development and introduction of the vaccination

More information

Below you will find information about diseases, the risk of contagion, and preventive vaccinations.

Below you will find information about diseases, the risk of contagion, and preventive vaccinations. Vaccinations Below you will find information about diseases, the risk of contagion, and preventive vaccinations. DTP - Diphtheria Tetanus Polio Yellow fever Hepatitis A Typhoid fever Cerebrospinal meningitis

More information

Poliomyelitis eradication in the WHO European Region

Poliomyelitis eradication in the WHO European Region Provisional agenda item 6(i) EUR/RC60/16 (+EUR/RC60/Conf.Doc./9) 23 July 2010 101614 ORIGINAL: ENGLISH Poliomyelitis eradication in the WHO European Region WHO Regional Committee for Europe Sixtieth session

More information

NHS Greater Glasgow & Clyde SOP No. BMT Haemopoietic Stem Cell Transplantation Services Vaccination Policy

NHS Greater Glasgow & Clyde SOP No. BMT Haemopoietic Stem Cell Transplantation Services Vaccination Policy This policy was written with advice from Dr S Ahmed, Consultant in Public Health, Greater Glasgow & Clyde. We would like to thank him for his guidance. 1. Background It is recommended by EBMT and CDC that

More information

Afghanistan: WHO and UNICEF estimates of immunization coverage: 2017 revision

Afghanistan: WHO and UNICEF estimates of immunization coverage: 2017 revision Afghanistan: WHO and UNICEF estimates of immunization coverage: 2017 revision July 7, 2018; page 1 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2019 data

More information

Ministry of health. Our Community

Ministry of health. Our Community Ministry of health Our Community This flip book is specially developed for Community Health Volunteer CHVs MUST ask 4 questions while using communication materials 1. What is happening in this picture?

More information

Recommended Childhood Immunization Schedu...ates, January - December 2000, NP Central

Recommended Childhood Immunization Schedu...ates, January - December 2000, NP Central Recommended Childhood Immunization Schedule United States, January - December 2000 Vaccines 1 are listed under routinely recommended ages. Solid-colored bars indicate range of recommended ages for immunization.

More information

THE NATIONAL CHILDHOOD IMMUNISATION PROGRAMMES IN SINGAPORE

THE NATIONAL CHILDHOOD IMMUNISATION PROGRAMMES IN SINGAPORE VOLUME 26, NO. 3 JUNE 1985 THE NATIONAL CHILDHOOD IMMUNISATION PROGRAMMES IN SINGAPORE K T Goh Quarantine & Epidemiology Department Princess House, Alexandra Road Singapore 0315 K T Goh MBBS, MSc, AM Head

More information

Immunization Report Public Health September 2013

Immunization Report Public Health September 2013 Immunization Report Public Health September 2013 Daycare, school entry and school program immunization enrollment rates, up to 2012 Table of Contents 1. Introduction... 2 2. Data Source... 2 3. Limitations...

More information

131. Public school enrollees' immunization program; exemptions

131. Public school enrollees' immunization program; exemptions TITLE 14. EDUCATION PART I. FREE PUBLIC SCHOOLS CHAPTER 1. DEPARTMENT OF EDUCATION SUBCHAPTER II. POWERS AND DUTIES 14 Del. C. 131 (2007) 131. Public school enrollees' immunization program; exemptions

More information

Teenage Booster Immunisation Statistics Scotland

Teenage Booster Immunisation Statistics Scotland Publication Report Teenage Booster Immunisation Statistics Scotland Teenage Td/IPV booster and teenage Men C booster immunisation uptake rates for school year 2014/15 Publication date 15 December 2015

More information

8: Applicability

8: Applicability Chapter 14 New Jersey State Sanitary Code Immunization of Pupils in Schools (New Jersey Administrative Code Citation 8:57-4.1 to 8:57-4.20) (Readopted with amendments September 20, 2003. Effective Date:

More information

Practical Applications of Immunology. Chapter 18

Practical Applications of Immunology. Chapter 18 Practical Applications of Immunology Chapter 18 I. Vaccines A. Definition A suspension of organisms or fractions of organisms that is used to induce immunity (immunologic memory). The mechanism of memory

More information

Polio Environmental Surveillance Enhancement Following Detection of Vaccine-Related Type-2 Poliovirus

Polio Environmental Surveillance Enhancement Following Detection of Vaccine-Related Type-2 Poliovirus 1. Goal and Objective: Although acute flaccid paralysis surveillance is the gold standard of polio surveillance, supplemental surveillance methods (which includes environmental surveillance (ES)) provide

More information

OUR BEST SHOT: The Truth About Vaccines for You and Your Loved Ones VACCINES. Produced in partnership with

OUR BEST SHOT: The Truth About Vaccines for You and Your Loved Ones VACCINES. Produced in partnership with OUR BEST SHOT: The Truth About Vaccines for You and Your Loved Ones VACCINES Produced in partnership with OUR BEST SHOT: The Truth About Vaccines for You and Your Loved Ones Vaccines are one of the greatest

More information

Progress in maternal and child health: Uzbekistan and WHO European Region

Progress in maternal and child health: Uzbekistan and WHO European Region Progress in maternal and child health: Uzbekistan and WHO European Region The National Model of Maternal and Child Health Protection in Uzbekistan: Zsuzsanna Jakab WHO Regional Director for Europe UZBEKISTAN

More information

NOTIFIABLE. 30 Tetanus. Introduction

NOTIFIABLE. 30 Tetanus. Introduction NOTIFIABLE 30 30.1 Introduction 30.1.1 is an acute disease characterised by muscular rigidity with superimposed agonising contractions. It is induced by the toxin of tetanus bacilli which grow anaerobically

More information

RAM U S. D E P A R T M E N T O F H E A L T H. E D U C A T IO N. AND W E LF A R E. J u l y 1970

RAM U S. D E P A R T M E N T O F H E A L T H. E D U C A T IO N. AND W E LF A R E. J u l y 1970 v u L.u n r. i. v, J u l y 1970 n u n w j y q 6/70 S2.2 J D MILLAR, MO, ACTING 01 RECTOR STATE AND COMMUNITY SERVICES D IV ISIO N BLOG B, ROOM 207 RAM I. C U R R E N T S M A L L P O X M O R B I D I T Y

More information

Measles, Mumps, Rubella (MMR) Vaccine discussion pack. an information guide for health professionals and parents

Measles, Mumps, Rubella (MMR) Vaccine discussion pack. an information guide for health professionals and parents Measles, Mumps, Rubella (MMR) Vaccine discussion pack an information guide for health professionals and parents The MMR discussion pack an information guide for health professionals and parents Published

More information

A PERTUSSIS EPIDEMIC IN NSW: HOW EPIDEMIOLOGY REFLECTS VACCINATION POLICY

A PERTUSSIS EPIDEMIC IN NSW: HOW EPIDEMIOLOGY REFLECTS VACCINATION POLICY A PERTUSSIS EPIDEMIC IN NSW: HOW EPIDEMIOLOGY REFLECTS VACCINATION POLICY Julia Brotherton and Jeremy McAnulty Communicable Diseases Branch NSW Department of Health Pertussis has traditionally been considered

More information

Pakistan: WHO and UNICEF estimates of immunization coverage: 2017 revision

Pakistan: WHO and UNICEF estimates of immunization coverage: 2017 revision Pakistan: WHO and UNICEF estimates of immunization coverage: 2017 revision July 7, 2018; page 1 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2019 data received

More information

Daycare, school entry and school program immunization report September Data for school years 2012/13 to 2014/15

Daycare, school entry and school program immunization report September Data for school years 2012/13 to 2014/15 Daycare, school entry and school program immunization report September 2015 Data for school years 2012/13 to 2014/15 Table of Contents Contents 1. Introduction... 0 2. Data Source... 1 3. Limitations...

More information

THANH TUNG MEDICAL STATION Annual Report 2014

THANH TUNG MEDICAL STATION Annual Report 2014 THANH TUNG MEDICAL STATION Annual Report 2014 Health-check at the medical station Christina Noble Children s Foundation - Vietnam Programme Description Established: 1999 Location: Target Group: Local Partner:

More information

Local CQUIN Template School Aged Immunisation Programmes

Local CQUIN Template School Aged Immunisation Programmes Local CQUIN Template Aged Immunisation Programmes 2017-2019 Indicator number Indicator name Aged Immunisation Programmes 2017-2019: Ensuring a wide spread of good coverage Indicator weighting (% of CQUIN

More information

Immunisation for pre-school children. three years and four months old

Immunisation for pre-school children. three years and four months old Immunisation for pre-school children three years and four months old Introduction This leaflet contains the facts about the diphtheria, tetanus, pertussis and polio booster vaccine, and the second MMR

More information

2018/19 Immunisation programmes list of additional and enhanced services

2018/19 Immunisation programmes list of additional and enhanced services 2018/19 Immunisation programmes list of additional and enhanced services 2018/19 Vaccination and Immunisation list of additional and enhanced services Version number: 1 First published: April 2018 Prepared

More information

UNSCHEDULED VACCINATION OF CHILDREN AND YOUNG PEOPLE WHO HAVE OUTSTANDING ROUTINE IMMUNISATIONS. Service Specification

UNSCHEDULED VACCINATION OF CHILDREN AND YOUNG PEOPLE WHO HAVE OUTSTANDING ROUTINE IMMUNISATIONS. Service Specification UNSCHEDULED VACCINATION OF CHILDREN AND YOUNG PEOPLE WHO HAVE OUTSTANDING ROUTINE IMMUNISATIONS Service Specification National Enhanced Service Specification For The Unscheduled Vaccination Of Children

More information

NHS GRAMPIAN IMMUNISATION PROGRAMMES ANNUAL REPORT 2010/11

NHS GRAMPIAN IMMUNISATION PROGRAMMES ANNUAL REPORT 2010/11 NHS GRAMPIAN IMMUNISATION PROGRAMMES ANNUAL REPORT 2010/11 NHS GRAMPIAN IMMUNISATION STEERING GROUP March 2012 1 Table of Content 1. Purpose of this report.3 2. Uptake of immunisation: key points during

More information

Guidelines for Implementation of Laboratory Containment of Wild Poliovirus

Guidelines for Implementation of Laboratory Containment of Wild Poliovirus Guidelines for Implementation of Laboratory Containment of Wild Poliovirus Laboratory Survey and National Inventory May 2000 EUR/00/5018753 E69379 EUROPEAN HEALTH21 TARGET 7 REDUCING COMMUNICABLE DISEASES

More information

patients with blood borne viruses Controlled Document Number: Version Number: 4 Controlled Document Sponsor: Controlled Document Lead:

patients with blood borne viruses Controlled Document Number: Version Number: 4 Controlled Document Sponsor: Controlled Document Lead: CONTROLLED DOCUMENT Procedure for the management of patients with blood borne viruses CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Version Number: 4 Controlled Document Sponsor: Controlled

More information

ANNEX Page. AFR/RC61/11 4 July 2011 ORIGINAL: ENGLISH REGIONAL COMMITTEE FOR AFRICA

ANNEX Page. AFR/RC61/11 4 July 2011 ORIGINAL: ENGLISH REGIONAL COMMITTEE FOR AFRICA 4 July 2011 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-first session Yamoussoukro, Côte d Ivoire, 29 August 2 September 2011 Provisional agenda item 16 PROGRESS REPORT ON POLIOMYELITIS ERADICATION

More information

Teenage Booster Immunisation Statistics Scotland

Teenage Booster Immunisation Statistics Scotland Teenage Booster Immunisation Statistics Scotland Uptake for School Year 2017/18 27 November 2018 An Official Statistics publication for Scotland This is an Official Statistics Publication The Official

More information

Downloaded from:

Downloaded from: Granerod, J; Davison, KL; Ramsay, ME; Crowcroft, NS (26) Investigating the aetiology of and evaluating the impact of the Men C vaccination programme on probable meningococcal disease in England and Wales.

More information

Polio Vaccine. By: Lia Schmitz, Pharm.D. Poliomylitis is a viral infection for which vaccination is generally given

Polio Vaccine. By: Lia Schmitz, Pharm.D. Poliomylitis is a viral infection for which vaccination is generally given Polio Vaccine By: Lia Schmitz, Pharm.D. Poliomylitis is a viral infection for which vaccination is generally given to infants and small children, and to people planning to travel to countries in which

More information

A case study in Pulse Polio Immunisation

A case study in Pulse Polio Immunisation Chapter 5 A case study in Pulse Polio Immunisation 5.1 Introduction This chapter features a worked example of Bayesian graphical modelling. Our data for this exercise are (i) the antibody measurements

More information

9/11/2018. Polio and Polio Vaccine. Poliomyelitis Disease. Poliovirus. First outbreak described in the U.S. in 1843

9/11/2018. Polio and Polio Vaccine. Poliomyelitis Disease. Poliovirus. First outbreak described in the U.S. in 1843 Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Polio and Polio Vaccine Chapter 18 September 2018 Photographs and images included in this presentation

More information

Early Learning Centre Immunisation Policy Legislation ACT Public Health Regulations (2000)

Early Learning Centre Immunisation Policy Legislation ACT Public Health Regulations (2000) Early Learning Centre Immunisation Policy Legislation ACT Public Health Regulations (2000) National Quality Standard / Education and Care Services National Regulations Standard 2.1 Each child s health

More information

Current Incident Status of Vaccine-Preventable Bacterial and Viral Infectious Diseases in Japan

Current Incident Status of Vaccine-Preventable Bacterial and Viral Infectious Diseases in Japan Research and Reviews Current Incident Status of Vaccine-Preventable Bacterial and Viral Infectious Diseases in Japan JMAJ 53(2): 106 110, 2010 Hajime KAMIYA,* 1 Tomoe SHIMADA,* 2 Nobuhiko OKABE* 3 Abstract

More information

Expanded Programme on Immunization (EPI)

Expanded Programme on Immunization (EPI) Indonesia 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles

More information

Case Studies in Ecology and Evolution. 10 The population biology of infectious disease

Case Studies in Ecology and Evolution. 10 The population biology of infectious disease 10 The population biology of infectious disease In 1918 and 1919 a pandemic strain of influenza swept around the globe. It is estimated that 500 million people became infected with this strain of the flu

More information

~~Middletowm, Connecticut

~~Middletowm, Connecticut R. J. C. PEARSON* D. G. MILLER* * Department of Epidemiology and Public M. L. PALMIERI*** Health, Yale University School of A. M.-M. PAYNEt Medicine and The Department of Health, J. R. J.R.PAULt D. M.

More information

WHO Polio Eradication Programme UK National Survey of Polioviruses

WHO Polio Eradication Programme UK National Survey of Polioviruses E WHO Polio Eradication Programme UK National Survey of Polioviruses A Paper submitted to the Health and Safety Committee Meeting, 17 th April 2008, by Alastair Reid. In September 2001, the University

More information

SHOULD VACCINES BE COMPULSORY?

SHOULD VACCINES BE COMPULSORY? The Big Debate SHOULD VACCINES BE COMPULSORY? Friday 02 March 2018 SHOULD VACCINES BE COMPULSORY? THE DILEMMA A change in French law means that all parents must now vaccinate children born on 1 January

More information

Expanded Programme on Immunization (EPI):

Expanded Programme on Immunization (EPI): Expanded Programme on Immunization (EPI): Introduction Four to five million annual deaths could be prevented by 2015 through sustained and appropriate immunization efforts, backed by financial support.

More information

11 Enforcement of the Immunization of School Pupils Act

11 Enforcement of the Immunization of School Pupils Act Clause 11 in Report No. 2 of Committee of the Whole was adopted, without amendment, by the Council of The Regional Municipality of York at its meeting held on February 18, 2016. 11 Enforcement of the Immunization

More information

Questions & Answers 1 November 2005 Vaccine Schedule

Questions & Answers 1 November 2005 Vaccine Schedule Questions & Answers 1 November 2005 Vaccine Schedule General Questions Q. When can clinics order the new vaccine? A. From early October 2005. Orders will be placed on back order & stock will be sent out

More information

Training for Inactivated Poliovirus Vaccine (IPV) introduction. Module 6. Inactivated poliovirus vaccine AEFI monitoring

Training for Inactivated Poliovirus Vaccine (IPV) introduction. Module 6. Inactivated poliovirus vaccine AEFI monitoring Training for Inactivated Poliovirus Vaccine (IPV) introduction Module 6 Inactivated poliovirus vaccine AEFI monitoring Learning objectives At the end of the module, the participants will be able to: Identify

More information

IPOL. Inactivated Poliomyelitis Vaccine. Consumer Medicine Information

IPOL. Inactivated Poliomyelitis Vaccine. Consumer Medicine Information IPOL Inactivated Poliomyelitis Vaccine What is in this leaflet Consumer Medicine Information This leaflet answers some common questions about IPOL vaccine. It does not contain all the available information.

More information

Evaluation on the Effectiveness of the National Childhood Immunisation Programme in Singapore,

Evaluation on the Effectiveness of the National Childhood Immunisation Programme in Singapore, 532 Singapore s Childhood Immunisation Programme Fereen Liew et al Original Article Evaluation on the Effectiveness of the National Childhood Immunisation Programme in Singapore, 1982-2007 Fereen Liew,

More information

Total population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000

Total population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000 India 4 Immunization system highlights There is a comprehensive multiyear plan (cmyp) for immunization covering 3-7. National technical advisory group on immunization (NTAGI) exists and formal written

More information

Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China Ding D, Kilgore P E, Clemens J D, Liu W, Xu Z Y

Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China Ding D, Kilgore P E, Clemens J D, Liu W, Xu Z Y Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China Ding D, Kilgore P E, Clemens J D, Liu W, Xu Z Y Record Status This is a critical abstract of an economic evaluation

More information

TEMPORARY PROGRAMME PERTUSSIS VACCINATION FOR PREGNANT WOMEN

TEMPORARY PROGRAMME PERTUSSIS VACCINATION FOR PREGNANT WOMEN TEMPORARY PROGRAMME PERTUSSIS VACCINATION FOR PREGNANT WOMEN Richard Smithson Neil Irvine Maureen McCartney Consultant Health Protection October 2012 Pertussis/whooping cough The disease Whooping Cough

More information

Nigeria: WHO and UNICEF estimates of immunization coverage: 2017 revision

Nigeria: WHO and UNICEF estimates of immunization coverage: 2017 revision Nigeria: WHO and UNICEF estimates of immunization coverage: 2017 revision July 7, 2018; page 1 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2019 data received

More information

GENERAL PRACTITIONER DATA PACK GUIDANCE

GENERAL PRACTITIONER DATA PACK GUIDANCE RESTRICTED For CQC internal use only This should NOT be shared outside CQC GENERAL PRACTITIONER DATA PACK GUIDANCE PRIMARY CARE DATA PACKS AND INSPECTION TEAM - November 2015 - Table of Contents Introduction...

More information

TRANSPARENCY COMMITTEE OPINION. 19 May 2010

TRANSPARENCY COMMITTEE OPINION. 19 May 2010 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 19 May 2010 HAVRIX NOURRISSONS ET ENFANTS 720 U/0.5 ml, suspension for injection in prefilled syringe. Inactivated,

More information

Poliomyelitis and Post Polio Syndrome. S.M. Mazloumi MD Associate professor

Poliomyelitis and Post Polio Syndrome. S.M. Mazloumi MD Associate professor Poliomyelitis and Post Polio Syndrome S.M. Mazloumi MD Associate professor What is Poliomyelitis? polio= gray matter Myelitis= inflammation of the spinal cord This disease result in the destruction of

More information

2017/18 Immunisation programmes list of additional and enhanced services

2017/18 Immunisation programmes list of additional and enhanced services 2017/18 Immunisation programmes list of additional and enhanced services 2017/18 Vaccination and Immunisation list of additional and enhanced services Version number: 1 First published: April 2017 Prepared

More information

Changes for the School Year

Changes for the School Year February 8, 2018 Dear Immunization Provider: In accordance with South Carolina Code of Laws, Section 44-29-180, and South Carolina Regulation 61-8, the 2017-2018 "Required Standards of Immunization for

More information

Reducing differences in the uptake of immunisation (PH21): Frequently asked questions for staff in Sure Start Children s Centres

Reducing differences in the uptake of immunisation (PH21): Frequently asked questions for staff in Sure Start Children s Centres Reducing differences in the uptake of immunisation (PH21): Frequently asked questions for staff in Sure Start Children s Centres This Frequently Asked Questions tool accompanies the public health guidance:

More information

Understanding the Roles of Different Bodies in Vaccine Decision Making: The Caribbean EPI Experience

Understanding the Roles of Different Bodies in Vaccine Decision Making: The Caribbean EPI Experience Understanding the Roles of Different Bodies in Vaccine Decision Making: The Caribbean EPI Experience Prof J Peter Figueroa Department of Community Health & Psychiatry University of the West Indies Kingston,

More information

Expanded Programme on Immunization (EPI)

Expanded Programme on Immunization (EPI) Bhutan 2017 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles containing

More information

Childhood Pneumonia & Meningitis: Recent Advances

Childhood Pneumonia & Meningitis: Recent Advances Childhood Pneumonia & Meningitis: Recent Advances Karachi, Pakistan January 31, 2009 MEDIA COVERAGE DAWN KARACHI, Pakistan February 1, 2009 Experts pin hopes on pentavalent vaccines A programme to introduce

More information

Global and National Trends in Vaccine Preventable Diseases. Dr Brenda Corcoran National Immunisation Office.

Global and National Trends in Vaccine Preventable Diseases. Dr Brenda Corcoran National Immunisation Office. Global and National Trends in Vaccine Preventable Diseases Dr Brenda Corcoran National Immunisation Office Global mortality 2008 Children under 5 years of age 1.5 million deaths due to vaccine preventable

More information

POLYVALENT SNAKE ANTIVENOM Product Information 1(5) Product Information POLYVALENT SNAKE ANTIVENOM (AUSTRALIA - PAPUA NEW GUINEA) AUST R 74899

POLYVALENT SNAKE ANTIVENOM Product Information 1(5) Product Information POLYVALENT SNAKE ANTIVENOM (AUSTRALIA - PAPUA NEW GUINEA) AUST R 74899 POLYVALENT SNAKE ANTIVENOM Product Information 1(5) Product Information NAME OF THE MEDICINE POLYVALENT SNAKE ANTIVENOM (AUSTRALIA - PAPUA NEW GUINEA) AUST R 74899 DESCRIPTION POLYVALENT SNAKE ANTIVENOM

More information

SURVEILLANCE TECHNICAL

SURVEILLANCE TECHNICAL CHAPTER 5 SURVEILLANCE TECHNICAL ASPECTS 55 Protect - detect - protect Polio eradication strategies can be summed up as protect and detect protect children against polio by vaccinating them, and detect

More information

THE RELAPSE IN SCARLET FEVER

THE RELAPSE IN SCARLET FEVER THE RELAPSE IN SCARLET FEVER BY JAMES S. ANDERSON, M.A., M.D., D.P.H., Medical Superintendent, Leeds City Hospitals, and Lecturer in Infectious Diseases, University of Leeds. In this country during the

More information

The hexavalent DTaP/IPV/Hib/HepB combination vaccine

The hexavalent DTaP/IPV/Hib/HepB combination vaccine The hexavalent DTaP/IPV/Hib/HepB combination vaccine Factsheet for healthcare professionals about the neonatal selective immunisation programme for babies at risk of hepatitis B Background All babies born

More information

Addendum to IPV Introduction Guidelines based on Recommendations of India Expert Advisory Group (IEAG)

Addendum to IPV Introduction Guidelines based on Recommendations of India Expert Advisory Group (IEAG) Addendum to IPV Introduction Guidelines based on Recommendations of India Expert Advisory Group (IEAG) Background India was certified polio-free along with 10 other countries of WHO South-East Asia Region

More information

Immunization and Vaccines

Immunization and Vaccines Immunization and Vaccines A parental choice Dr. Vivien Suttorp BSc, MPH, MD, CCFP, FCFP Lead Medical Officer of Health South Zone, Alberta Health Services November 7, 2013 Overview Facts about vaccines

More information

Public Health Applications in Pharmacy

Public Health Applications in Pharmacy 1 Pharmacy 445 Public Health Applications in Pharmacy Jacqueline Gardner, Ph.D. Professor, Department of Pharmacy 2 Public or Community Health Distinct from clinical medicine, which focuses upon an individual

More information

Expanded Programme on Immunization (EPI)

Expanded Programme on Immunization (EPI) Sri Lanka 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS Registration No. 1B 12/46 Importer / Manufacturer: GPO-MBP SUMMARY OF PRODUCT CHARACTERISTICS 1. ME OF THE MEDICAL PRODUCT ORAL POLIOMYELITIS VACCINE 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One vaccine

More information

Changes to the Meningococcal C conjugate (MenC) vaccine schedule. Questions and Answers

Changes to the Meningococcal C conjugate (MenC) vaccine schedule. Questions and Answers Changes to the Meningococcal C conjugate (MenC) vaccine schedule Questions and Answers Background The meningococcal C (MenC) vaccination programme was first introduced into the UK routine immunisation

More information

I protected my future

I protected my future I protected my future I had all my vaccinations Ask at home today if you ve had your vaccinations. Developed by Pfizer Ltd in collaboration with PHE and Wiltshire Council. March 2014. NPSC0069c Everybody

More information

A Procedure for the management of Meningitis/Septicaemia in the University

A Procedure for the management of Meningitis/Septicaemia in the University 1. Introduction A Procedure for the management of Meningitis/Septicaemia in the University Meningitis/septicaemia is a rare but potentially fatal infection occurring mostly in young children. Over the

More information

Nationwide Oral Poliovirus Vaccination Campaign and the Incidence of Guillain-Barre Syndrome

Nationwide Oral Poliovirus Vaccination Campaign and the Incidence of Guillain-Barre Syndrome American Journal of Epidemiology Copyright O 1998 by The John3 Hopkins University School of Hygiene and Public Health AD rights reserved Vol. 147, No. 1 Printed In USA. Nationwide Oral Poliovirus Vaccination

More information

International PolioPlus Committee PolioPlus Facts and Figures June Rotary s financial contribution to the polio eradication effort:

International PolioPlus Committee PolioPlus Facts and Figures June Rotary s financial contribution to the polio eradication effort: International PolioPlus Committee PolioPlus Facts and Figures June 2018 1. The goal of the PolioPlus program: The goal of the PolioPlus program is the global certification of polio eradication. By eradication,

More information

AIDA M. SALONGA, MD, FPNA, FCNSP CHAIR, AFP EXPERT PANEL, DOH MEMBER, REGIONAL CERTIFICATION COMMITTEE, WHO

AIDA M. SALONGA, MD, FPNA, FCNSP CHAIR, AFP EXPERT PANEL, DOH MEMBER, REGIONAL CERTIFICATION COMMITTEE, WHO POLIO FAQs on ENDGAME Tuberculosis AIDA M. SALONGA, MD, FPNA, FCNSP CHAIR, AFP EXPERT PANEL, DOH MEMBER, REGIONAL CERTIFICATION COMMITTEE, WHO OBJECTIVES Brief history of poliomyelitis Polio eradication:

More information